- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0001576

Bindlysh Biotec Limited
About Bindlysh Biotec Limited
Data last updated:
Bindlysh Biotec Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 September 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PLC089595. Its GSTIN is 07AAACB8892L1Z4 (Delhi).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Prerak Gupta and Vijesh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 45 Jhilmill Indl. Area, Delhi, India – 110095.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.68 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹2.67 Lakh (net margin 0.6%) and EBITDA of ₹30.65 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹40.83 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
Bindlysh Biotec Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0001576). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Bindlysh Biotec
Contact details
Bindlysh Biotec Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 45 Jhilmill Indl. Area, Delhi, India – 110095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bindlysh Biotec Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bindlysh Biotec is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bindlysh Biotec Limited, buy the company report.
Financials of Bindlysh Biotec Limited
FY 2024 filings availableBindlysh Biotec Limited reported revenue of ₹4.68 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 15% fall in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bindlysh Biotec Limited, buy the company report.
Board of directors of Bindlysh Biotec Limited
Bindlysh Biotec has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prerak Gupta | Director | 03 Jul 2017 | 9 Years 4 Months | Current |
| Vijesh Gupta | Director | 11 Sep 1997 | 29 Years 2 Months | Current |
| Ragini Vijesh Gupta | Director | 11 Sep 1997 | 29 Years 2 Months | Current |
Auditor
Bindlysh Biotec Limited is audited by P R P A AND Company LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P R P A AND Company LLP | FY 2023 | N500344 |
Shareholding
The shareholding of Bindlysh Biotec Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bindlysh Biotec Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jan 2022 | 100543103 | Hdfc Bank Limited | ₹20.83 Lakh | Open | |
| 03 Nov 2001 | 90036859 | Canara Bank | ₹20 Lakh | Open |
To see the full charge records of Bindlysh Biotec Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Bindlysh Biotec Limited has 2 court cases on record: 1 filed by Bindlysh Biotec, 1 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Civil suit | Filed by the company against individuals | Pending |
| District court, Shahdara, Delhi | Court case (Civ Suit) | Filed against the company by an individual | Disposed |
To see the full case history of Bindlysh Biotec Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bindlysh Biotec Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bindlysh Biotec has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACB8892L1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bindlysh Biotec Limited, buy the company report.
Recent activity
Bindlysh Biotec Limited has 5 board changes on record since 1997: 3 appointments and 2 cessations. The latest: Shalini Jain ceased to be Director on 25 Sep 2022.
Frequently asked questions
Bindlysh Biotec is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 September 1997 (29+ years old) and is registered under CIN U24231DL1997PLC089595.
Bindlysh Biotec has 3 current directors:
- Prerak Gupta - Director
- Vijesh Gupta - Director
- Ragini Vijesh Gupta - Director
The latest financial statements of Bindlysh Biotec on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bindlysh Biotec is 07AAACB8892L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Bindlysh Biotec is U24231DL1997PLC089595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bindlysh Biotec has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
Bindlysh Biotec was incorporated on 11 September 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Shalini Jain ceased to be Director on 25 Sep 2022. Prerak Gupta ceased to be Additional Director on 29 Sep 2017. Prerak Gupta was appointed as Director on 03 Jul 2017. Bindlysh Biotec has 5 board changes on record in total.
Yes, Bindlysh Biotec is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0001576).
The registered office of Bindlysh Biotec is at A – 45 Jhilmill Indl. Area, Delhi, India – 110095.

